Navigation Links
Studies challenge standards to improve treatment outcomes for patients with clotting disorders
Date:12/8/2012

tract 4]

In the first randomized clinical trial assessing the proper target hematocrit level, or percentage of red blood cells that should be maintained in patients with polycythemia vera (PV), researchers have concluded that the current recommendation to maintain a hematocrit level of less than 45 percent is associated with a lower risk of thrombosis compared with a less aggressive treatment strategy of maintaining a hematocrit level between 45 and 50 percent.

PV is a rare blood disorder that causes the bone marrow to produce too many red blood cells, making the blood much thicker.This can dramatically increase the risk of blood clots such as deep-vein thrombosis (DVT, a blood clot that forms in a vein deep in the legs) or pulmonary embolism (PE, a blood clot in the lung) and cardiovascular events such as heart attack or stroke. Because thrombosis is the most common cause of death in patients with PV, prompt diagnosis and treatment to reduce the thickness of the blood is critical.

Patients with PV usually have elevated hematocrit levels (approximately 50 to 70%, compared with less than 50% in the general population), which puts them at a higher risk of suffering heart attacks, strokes, and DVT/PE than the general population. In order to reduce this risk, a hematocrit level of less than 45 percent is recommended and initially maintained through phlebotomies. If the hematocrit level cannot be reduced through multiple phlebotomies or disease progression is documented, patients receive hydroxyurea or chemotherapy to eliminate the excess red blood cells. While these two treatment strategies have become widely accepted for PV, until recently no prospective randomized clinical trial has confirmed whether tight control of hematocrit levels below 45 percent successfully prevents or reduces blood clots in patients with PV.

In order to assess the efficacy and safety of maintaining a hematocrit level of lower than 45 percent versus a mo
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
2. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
3. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
4. Sharp spike in computer-related injuries predicted for medical workers, find studies
5. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
6. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
7. New studies show effects of mammography guideline changes
8. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
9. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
10. Cancer Drug Reduced Relapses in MS Patients: Studies
11. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... 2014 The report “TS-1 (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... an anti-cancer drug which is typically used for treating ... used for treating gastric cancer and pancreatic cancer. TS-1 ... drug was first approved in 1999 in Japan for ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 The short film ... was created in honor of a true 9/11 hero, Welles ... film festivals including the 24 hours of Nuremberg International Short ... Bangladesh. , Actress, screenwriter and director Luciana Lagana ... this film together with her husband, Gregory Graham ...
(Date:12/25/2014)... 25, 2014 Recently, LunaDress.co.uk has updated its blog ... related accessories. Now, all of the models at LunaDress.co.uk come with ... groom lifts the wedding veil can turn out to be a ... A wedding veil can always bring surprise to a wedding. On ... how to choose veils for a big day . , ...
(Date:12/25/2014)... By Dennis Thompson ... -- Researchers could be closing in on a "fountain of ... improve the health of older adults, a new study suggests. ... when given a drug that targets a genetic signaling pathway ... maker Novartis report. The experimental medication, a ...
(Date:12/25/2014)... December 25, 2014 Residents at ... Community, recently showed their generous spirit by providing ... Catawba County Parenting Network- Grandparents Raising Grandchildren program. ... gathered around the largest Christmas tree on the ... purchased by residents of the Abernethy Village Association ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
... first to tackle different forms of the disease and help ... new vaccine is designed to trigger production of a range ... causing the disease. Scientists created the vaccine by ... types of malaria parasite, which is known to trigger production ...
... A vaccine to prevent anal cancer is safe and effective ... funded in part by the vaccine,s maker. Anal cancer ... sexually transmitted disease in the United States. Anal cancer is ... with HIV. , , Merck,s Gardasil vaccine is already ...
... 11-month-old partnership between UCSF and Pfizer, Inc., aimed at ... selected its first projects for funding and joint development. ... on experimental therapies developed by the UCSF scientists with ... hard-to-treat, often deadly conditions, including lung and prostate cancer. ...
... News) -- Moving to the beat of music actually helps ... Researchers at McMaster University in Canada played a series ... on an electronic drum pad while they listened while the ... whether the final beat was consistent with the preceding rhythm, ...
... WEDNESDAY, Oct. 26 (HealthDay News) -- The genes suspected of ... the developing brain before birth, according to a major genetic ... spotted hundreds of genetic differences between males and females still ... genes involved in the development of the brain, but now ...
... estimate, half of Americans are confronting a civil legal problem at ... advice, or an advocate in civil court, they may lose a ... They may lose out in a divorce, or in a billing ... those services depends not on their need but where they live, ...
Cached Medicine News:Health News:Multiple malaria vaccine offers protection to people most at risk 2Health News:HPV Vaccine Might Help Prevent Anal Cancers: Study 2Health News:UCSF-Pfizer partnership yields projects aimed at clinical trials 2Health News:UCSF-Pfizer partnership yields projects aimed at clinical trials 3Health News:UCSF-Pfizer partnership yields projects aimed at clinical trials 4Health News:Links to Mental Illness Seen in Fetal Brains: Study 2Health News:Access to legal aid depends a lot on where you live, report says 2Health News:Access to legal aid depends a lot on where you live, report says 3
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
(Date:12/22/2014)... MEMPHIS, Tenn. , Dec. 22, 2014   ... only automated, no-touch UV disinfection robot, announced today that ... GSA Schedule contract through November 2019.   ... to rapidly engage all levels of government purchasers, including ... facilities, as well as Homeland Security contacts purchasing solutions ...
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 ... Pharmaceuticals, Inc. today announced that the Committee for Medicinal ... Agency (EMA) has adopted a positive opinion for the ... of adult men with Peyronie,s disease with a palpable ... at the start of therapy. The use ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... found to be prevalent in cancer patients regardless of nutritional ... at Cancer Treatment Centers of America ... for vitamin D deficiency and aggressive vitamin D repletion should ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090612/CTCALOGO ) , ...
... Jazz Pharmaceuticals, (Nasdaq: JAZZ ) sodium oxybate ... and the core symptoms associated with fibromyalgia, according to Phase ... Sleep Societies meeting in Seattle, WA. These data have ... for use of sodium oxybate in the treatment of fibromyalgia. ...
Cached Medicine Technology:Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients 2Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia 2Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia 3Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia 4Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia 5
Both versions of the UltraSling II provide immobilization for rotator cuff repairs, capusular shifts, Bankhart repairs, glenohumeral dislocations/subluxation and soft tissue repairs/strains....
Unique V-lock strapping system prevents roll and shifting to provide secure shoulder immobilization...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Effective spinal bracing is a critical component ... surgical stabilization. The Aspen® Lumbosacral Bracing System™ ... provide a high degree of immobilization, unparalled ... patients . . . even if they ...
Medicine Products: